Pfizer keeps 2022 COVID-19 vaccine, pill sales outlook unchanged
The move disappointed investors who were hoping products would continue to drive growth.The move disappointed investors who were hoping products would continue to drive growth.The move disappointed investors who were hoping products would continue to drive growth.External Content
| Source | RSS or Atom Feed |
| Feed Location | https://www.aljazeera.com/xml/rss/all.xml |
| Feed Title | Al Jazeera – Breaking News, World News and Video from Al Jazeera |
| Feed Link | https://www.aljazeera.com/ |
| Feed Copyright | © 2025 Al Jazeera Media Network |
| Reply | 0 comments |